Case Report
Early initiation of awake venovenous extracorporeal membrane oxygenation (ECMO) in critical COVID-19 pneumonia: A case reports

https://doi.org/10.1016/j.amsu.2021.102641Get rights and content
Under a Creative Commons license
open access

Highlights

  • Extracorporeal membrane oxygenation (ECMO) is extracorporeal life support used as salvage therapies in patients with acute cardiac, pulmonary or cardiopulmonary failure.

  • Early initiation of awake venovenous extracorporeal membrane oxygenation (ECMO) in critical cases of COVID-19 infection.

  • “Awake ECMO” support in patients with COVID-19 is feasible and has benefits in the absence of mechanical ventilation.

Abstract

Introduction

Overall, patients with Sars-cov-2 disease treated with mechanical ventilation, which is not the case in our study. This report presents our first successful experience of awake ECMO application in a critical patient with hypoxemic Respiratory Failure related to COVID-19 infection in Morocco.

Case management

We have reported a 52-year-old female patient who was diagnosed with COVID-19 infection and progressed to critical cases. She was a candidate for applying awake extracorporeal membrane oxygenation (ECMO) in the absence of invasive mechanical ventilation, under local anesthesia alone with good progress and ventilatory weaning.

Conclusion

This therapeutic attitude can be beneficial for certain critical and severe cases due to COVID-19 infection. Each ECMO program should develop goals, methods, protocols, and best practices while adapting appropriately to the personnel and equipment available.

Keywords

Extracorporeal membrane oxygenation
Venovenous ECMO
Acute respiratory distress syndrome
COVID-19
Awake
Case report

Cited by (0)